KEGG pathways such as IL-17 signaling, TNF signaling, non-alcoholic fatty liver disease, and pathways in cancer were significantly enriched, consistent with the module’s role in amplifying inflammatory cascades, metabolic imbalance, and immune-mediated tissue injury. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.